Maria Paula Rampulla, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 590 Benzing Rd, Antioch, TN 37013 Phone: 615-988-2340 Fax: 615-988-2643 |
Dr. Susan Williams, ED.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 636 Mount Hood Dr, Antioch, TN 37013 Phone: 615-366-6999 |
Dr. Ronald Lawrence Roberts, PH.D. Psychologist - Health Service Medicare: Not Enrolled in Medicare Practice Location: 201 Claybrook Ln, Antioch, TN 37013 Phone: 615-477-7701 |
Dezerie Pope Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 1108 Cedarhill Dr, Antioch, TN 37013 Phone: 615-738-0387 |
Gregory Joe Pearson, M.S. Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 5170 Hickory Hollow Pkwy Apt 406, Antioch, TN 37013 Phone: 615-479-5714 |
Enzo Enias Jonga Psychologist - Family Medicare: Not Enrolled in Medicare Practice Location: 3001 Hamilton Church Rd, Unit 443, Antioch, TN 37013 Phone: 615-775-6690 |
News Archive
A study by the Faculty of Physiotherapy of the University of Valencia (UV), in collaboration with the Autonomous University of Madrid, has shown that a physiotherapy programme that uses the Nintendo Wii console improves the functionality, balance and daily activities of patients who have suffered a cerebrovascular accident or stroke.
The study revealed that a variant of a protein involved in HIV pathogenesis can suppress production of an HIV protein, known as Nef. Nef is required for the human immunodeficiency virus to develop into AIDS through a series of complex events involving viral elements and cellular proteins. Nef has never been a target for drug treatment in HIV patients.
As state and local policymakers and politicians made the decision to enact stay-at-home orders last March in response to the coronavirus pandemic, a recent study found that more stringent public health measures put in place directly correlated with lower virus case numbers during the first two months of the pandemic.
In its first clinical trial, a breakthrough antibody therapy produced at least partial remissions in a third of patients with multiple myeloma who had exhausted multiple prior treatments, investigators at Dana-Farber Cancer Institute and other organizations report today online in the New England Journal of Medicine.
› Verified 8 days ago